DK0669971T3 - Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner - Google Patents

Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner

Info

Publication number
DK0669971T3
DK0669971T3 DK92925307T DK92925307T DK0669971T3 DK 0669971 T3 DK0669971 T3 DK 0669971T3 DK 92925307 T DK92925307 T DK 92925307T DK 92925307 T DK92925307 T DK 92925307T DK 0669971 T3 DK0669971 T3 DK 0669971T3
Authority
DK
Denmark
Prior art keywords
vaccine
gram
negative bacterial
preparation
pct
Prior art date
Application number
DK92925307T
Other languages
Danish (da)
English (en)
Inventor
David S Roberts
Donald A Dearwester
Leroy A Swearingin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0669971T3 publication Critical patent/DK0669971T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK92925307T 1991-11-15 1992-11-13 Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner DK0669971T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79248891A 1991-11-15 1991-11-15
PCT/US1992/009944 WO1993010216A1 (fr) 1991-11-15 1992-11-13 Vaccins bacteriens gram-negatifs

Publications (1)

Publication Number Publication Date
DK0669971T3 true DK0669971T3 (da) 2003-04-22

Family

ID=25157051

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92925307T DK0669971T3 (da) 1991-11-15 1992-11-13 Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner

Country Status (10)

Country Link
US (1) US5616328A (fr)
EP (1) EP0669971B1 (fr)
JP (1) JP3043809B2 (fr)
AT (1) ATE234916T1 (fr)
AU (1) AU667858B2 (fr)
CA (1) CA2123222C (fr)
DE (1) DE69232969T2 (fr)
DK (1) DK0669971T3 (fr)
ES (1) ES2194841T3 (fr)
WO (1) WO1993010216A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051240A (en) * 1994-04-28 2000-04-18 Takeda Chemical Industries, Ltd. Method of separating protective components of Bordetella pertussis
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
US6713071B1 (en) * 1998-10-22 2004-03-30 Pfizer Inc. Proteins from actinobacillus pleuropneumoniae
AU776847B2 (en) * 1999-01-29 2004-09-23 Zoetis Services Llc Erysipelothrix rhusiopathiae antigens and vaccine compositions
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US6765372B2 (en) 2001-12-14 2004-07-20 Intersil Americas Inc. Programmable current-sensing circuit providing continuous temperature compensation for DC-DC Converter
CA2508825A1 (fr) * 2002-12-18 2004-07-01 Techno Network Shikoku Co., Ltd. Vaccin contre l'infection a bacteries cryophiles des poissons
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine
WO2006029223A2 (fr) * 2004-09-08 2006-03-16 Children's Medical Center Corporation Methode de stimulation de la reponse immunitaire chez des nouveau-nes
WO2013095973A1 (fr) 2011-12-19 2013-06-27 The Rockefeller University Peptides de liaison à hdc-sign
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
WO2022114921A1 (fr) * 2020-11-30 2022-06-02 주식회사 엘지화학 Procédé d'élimination d'endotoxine dérivée de bordetella pertussis dans un vaccin associé multivalent au moyen d'un excipient d'aluminium
CN113670914B (zh) * 2021-08-19 2024-03-08 青岛易邦生物工程有限公司 一种油乳剂灭活疫苗的细菌内毒素检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4465665A (en) * 1982-03-04 1984-08-14 Smithkline-Rit Detoxified E. coli neurotoxin, preparation thereof and immunological preparations containing it
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
US5019388A (en) * 1986-10-14 1991-05-28 Norden Laboratories Inc. Bordetella bronchiseptica vaccine
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
WO1991019419A1 (fr) * 1990-06-13 1991-12-26 Smithkline Beecham Corporation Vaccins contre l'anatoxine pasteurella multocida

Also Published As

Publication number Publication date
CA2123222C (fr) 2001-02-27
US5616328A (en) 1997-04-01
DE69232969D1 (de) 2003-04-24
ES2194841T3 (es) 2003-12-01
EP0669971A1 (fr) 1995-09-06
AU667858B2 (en) 1996-04-18
JPH07501333A (ja) 1995-02-09
JP3043809B2 (ja) 2000-05-22
EP0669971A4 (fr) 1995-04-19
EP0669971B1 (fr) 2003-03-19
DE69232969T2 (de) 2004-08-05
WO1993010216A1 (fr) 1993-05-27
AU3141393A (en) 1993-06-15
ATE234916T1 (de) 2003-04-15
CA2123222A1 (fr) 1993-05-27

Similar Documents

Publication Publication Date Title
DK0669971T3 (da) Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
IL138798A0 (en) Vaccines and antibodies against bacterial pneumococcal infection
RU94046145A (ru) Комбинированные вакцины, содержащие поверхностный антиген гепатита в и другие антигены, способ их получения, способ предупреждения инфекций гепатита в
DK0749321T3 (da) Aktiv immunisering under anvendelse af et sideroforreceptorprotein
NO1997010I1 (no) Bordetella pertussis P69 antigen
CA2022420A1 (fr) Vaccin contre escherichia coli
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
ATE356633T1 (de) Vakzin für einen nicht typisierbaren haemophilus influenzae stamm
DK0600396T3 (da) Vacciner mod tarmprotozoer
EP0090660A3 (fr) Vaccin anti-gonococcique
ATE258445T1 (de) Impfstoff beinhaltend bacterin und toxoid aus pasteurella haemolytica typ a-1
AU673344B2 (en) Vaccines based on streptokinase
IL122829A0 (en) Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
AU4778297A (en) Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same
DK0570682T3 (da) Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner
TH6102A (th) วัคซีนป้องกันโรคบิดในหมู
SE8303096L (sv) Lagtoxiskt kikhostevaccin